Parametrica Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Parametrica Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,927	Closed	-$306K	–	443
2017 Q4	$306K	Buy	+2,927	New	+$322K	0.19%	193
2016 Q4	–	Sell	-4,327	Closed	-$478K	–	277
2016 Q3	$478K	Buy	4,327 +2,727	+170%	+$361K	1.32%	6
2016 Q2	$233K	Buy	+1,600	New	+$227K	0.35%	150

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametrica Management's TARO Position: Q1 2018 in Review

Parametrica Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 2,927 shares — an estimated $306K sold.

Parametrica Management first reported a position in TARO in Q2 2016 and held it in 3 quarters. The position peaked at $478K in Q3 2016. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

Parametrica Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
Parametrica Management sold 2,927 Taro Pharmaceutical Industries Ltd. shares in Q1 2018, an estimated $306K.
Parametrica Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 3 quarters.
Parametrica Management's Taro Pharmaceutical Industries Ltd. position peaked at $478K in Q3 2016.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Parametrica Management's 13F filing for Q1 2018, filed 24 Apr 2018.